Sabre Corporation SABR 深 沪
等待开盘 03-27 09:30:00 美东时间
1.525
+0.015
+0.99%
华盛通- 最 高1.58
- 今 开1.52
- 成交量 584.97万股
- 最 低 1.48
- 昨 收 1.51
- 总市值 6.03亿
- 52周最高 3.52
- 市盈率 静 1.14
- 换手率 1.48%
- 52周最低 0.81
- 委 比 4.60%
- 总股本 3.95亿
- 历史最高 28.025
- 量 比 1.08
- 振 幅 6.62%
- 历史最低 0.81
- 每 手 1
- 风险率 0.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sabre Announces Extension Of Partnership With TNS Global To Strengthen Its Position In East Africa
- Sabre Corporation (NASDAQ:SABR), a leading global travel technology company, today announced an extension of its distribution representation agreement with TNS Global to encompass three East African markets: Kenya,
03-24 03:23
Sabre Appoints Niklas Andréen as Chief Commercial Officer, Airline Tech
New leadership role underscores Sabre's commitment to accelerating airline growth and innovation following its AI-native platform rebuild SOUTHLAKE, Texas, March 10, 2026 /PRNewswire/ -- Sab...
03-10 21:00
Sabre and Constellation Software Enter into Strategic Governance Agreement
Sabre Appoints Damian McKay to Board of Directors as a Representative of Constellation SOUTHLAKE, Texas and TORONTO, March 5, 2026 /PRNewswire/ -- Sabre Corporation (NASDAQ: SABR) ("Sabre" o...
03-06 06:17
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Gainers Polibeli Group (NASDAQ:PLBL) stock moved upwards by 22.3% to $9.67 dur...
03-06 01:05
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Wall Street analysts changed ratings on top companies. See full list at benzinga.com/analyst-stock-ratings. MDB outlook downgraded to Neutral.
03-03 21:39
Bernstein Downgrades Sabre to Market Perform, Announces $1.5 Price Target
Bernstein analyst Alex Irving downgrades Sabre (NASDAQ:SABR) from Outperform to Market Perform and announces $1.5 price target.
03-03 20:11
Sabre posts FY 2025 normalized adjusted EBITDA of USD 536M, up 10%
Sabre posts FY 2025 normalized adjusted EBITDA of USD 536M, up 10% Sabre reported Q4 FY 2025 revenue of USD 667 million (+3%) and normalized adjusted EBITDA of USD 119 million (+10%), with a normalized adjusted EBITDA margin of 18% (up 107 bps). Q4 pro forma free cash flow was USD 116 million, inclu
03-03 15:13
Sabre Q4 revenue rises 3% to USD 667 million
Sabre Q4 revenue rises 3% to USD 667 million Sabre reported Q4 FY2025 revenue of USD 667.0 million (+3.0%), including Distribution revenue of USD 526.8 million (+5.0%) and IT Solutions revenue of USD 139.7 million (-4.0%). Q4 operating income was USD 21.3 million (-54.0%), while net loss attributabl
03-03 15:12
Sabre Unveils AI-First Sabre Mosaic Platform at ITB Berlin 2026
Sabre Unveils AI-First Sabre Mosaic Platform at ITB Berlin 2026 Sabre Corporation attended ITB Berlin 2026, where it unveiled the results of a multiyear technology rebuild and introduced its unified, AI-first Sabre Mosaic platform. The company highlighted its AI-native, cloud-based architecture powe
03-03 15:11
